HIGHLIGHTS
- who: Rheumatol Int ( et al. from the NSarlet Bone and Cartilage Metabolism Research Unit, Department of Geriatrics, CHU Centre Ville, University of Liège, Liège, Belgium have published the article: Role of glucosamine in the treatment for osteoarthritis, in the Journal: (JOURNAL)
- what: Health economics A study was designed to explore the cost-effectiveness of GS compared with paracetamol and placebo (PBO) in the treatment for knee osteoarthritis, and a 6-month time horizon and a health care perspective were used.
SUMMARY
Symptomatic effects in osteoarthritis Efficacy and safety of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.